Published in J Atheroscler Thromb on December 16, 2009
Multi-target drugs: the trend of drug research and development. PLoS One (2012) 1.28
The oxidized low-density lipoprotein receptor mediates vascular effects of inhaled vehicle emissions. Am J Respir Crit Care Med (2011) 1.13
Vascular and cardiac impairments in rats inhaling ozone and diesel exhaust particles. Environ Health Perspect (2010) 1.07
CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme. J Lipid Res (2011) 0.95
Minocycline ameliorates LPS-induced inflammation in human monocytes by novel mechanisms including LOX-1, Nur77 and LITAF inhibition. Biochim Biophys Acta (2012) 0.93
Soluble lectin-like oxidized low density lipoprotein receptor-1 as a biochemical marker for atherosclerosis-related diseases. Dis Markers (2013) 0.86
Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial. BMC Complement Altern Med (2015) 0.82
Ginkgolide B reduces LOX-1 expression by inhibiting Akt phosphorylation and increasing Sirt1 expression in oxidized LDL-stimulated human umbilical vein endothelial cells. PLoS One (2013) 0.81
Effect of rosuvastatin dose-loading on serum sLox-1, hs-CRP, and postoperative prognosis in diabetic patients with acute coronary syndromes undergoing selected percutaneous coronary intervention (PCI). Int J Clin Exp Med (2015) 0.78
Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia. Biomed Res Int (2014) 0.76
Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease. World J Gastroenterol (2015) 0.75
Serum sLOX-1 Levels Are Correlated with the Presence and Severity of Obstructive Sleep Apnea. Genet Test Mol Biomarkers (2015) 0.75
Role of antioxidant property of carvedilol in mild to moderate hypertensive patients: A prospective open-label study. Indian J Pharmacol (2016) 0.75
Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon. Arch Med Sci (2016) 0.75
Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells. PLoS One (2015) 0.75
Elucidation of the Role of Lectin-Like oxLDL Receptor-1 in the Metabolic Responses of Macrophages to Human oxLDL. J Lipids (2017) 0.75
Advanced Maternal Age Worsens Postpartum Vascular Function. Front Physiol (2017) 0.75
Drug eluting balloon: a multipurpose tool for coronary revascularization with optimal long-term follow-up results. J Interv Cardiol (2014) 2.47
Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol (2010) 2.24
[GISE/AIAC position paper on percutaneous left atrial appendage occlusion in patients with nonvalvular atrial fibrillation: recommendations for patient selection, facilities, competences, organizing and training requirements]. G Ital Cardiol (Rome) (2014) 1.98
Endovascular treatment of patients with types A and B thoracic aortic dissection using Relay thoracic stent-grafts: results from the RESTORE Patient Registry. J Endovasc Ther (2011) 1.58
Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study. Thromb Res (2005) 1.54
Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study. Catheter Cardiovasc Interv (2011) 1.50
Drug-eluting stents versus bare-metal stents in acute ST-segment elevation myocardial infarction. a single-center experience with long-term follow up. J Invasive Cardiol (2010) 1.45
Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J Clin Endocrinol Metab (2006) 1.44
Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function. Ann Thorac Surg (2009) 1.42
Comparative efficacy and safety of anticoagulant strategies for acute coronary syndromes. Comprehensive network meta-analysis of 42 randomised trials involving 117,353 patients. Thromb Haemost (2015) 1.40
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res (2015) 1.39
The omega-3 fatty acid docosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKC epsilon inhibition. Proc Natl Acad Sci U S A (2006) 1.32
At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol (2005) 1.27
Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis (2003) 1.26
Nutritional mechanisms that influence cardiovascular disease. Am J Clin Nutr (2006) 1.18
Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Respir Res (2011) 1.15
Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention (2016) 1.11
A prospective randomized trial of thrombectomy versus no thrombectomy in patients with ST-segment elevation myocardial infarction and thrombus-rich lesions: MUSTELA (MUltidevice Thrombectomy in Acute ST-Segment ELevation Acute Myocardial Infarction) trial. JACC Cardiovasc Interv (2012) 1.04
Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products. Diabetes (2004) 1.01
Circulating levels of lectin-like oxidized low-density lipoprotein receptor-1 are associated with inflammatory markers. Lipids (2008) 1.00
Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis. Atherosclerosis (2010) 0.96
Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab (2011) 0.95
In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound. Cardiovasc Res (2003) 0.95
Sizing the aortic annulus. Ann Cardiothorac Surg (2012) 0.94
An update on advanced glycation endproducts and atherosclerosis. Biofactors (2012) 0.93
Quenching of intracellular ROS generation as a mechanism for oleate-induced reduction of endothelial activation and early atherogenesis. Thromb Haemost (2002) 0.91
A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions. J Am Coll Cardiol (2012) 0.90
Hybrid repair of a Kommerell's diverticulum aneurysm. J Card Surg (2009) 0.90
Transcatheter valve in valve implantation for failed mitral and tricuspid bioprosthesis. Catheter Cardiovasc Interv (2011) 0.90
Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutat Res (2005) 0.89
What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? Liver Transpl (2011) 0.89
C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization. Int J Cardiol (2004) 0.87
European registry on patients with ST-elevation myocardial infarction transferred for mechanical reperfusion with a special focus on early administration of abciximab -- EUROTRANSFER Registry. Am Heart J (2008) 0.86
Predictive value of less than moderate residual mitral regurgitation as assessed by transesophageal echocardiography for the short-term outcomes of patients with mitral regurgitation treated with mitral valve repair. Cardiovasc Ultrasound (2007) 0.86
Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links. J Cardiovasc Med (Hagerstown) (2007) 0.85
The effect of Ginkgo biloba in isolated ischemic/reperfused rat heart: a link between vitamin E preservation and prostaglandin biosynthesis. J Cardiovasc Pharmacol (2004) 0.85
Aberrant right subclavian artery aneurysm in coexistence with a common carotid trunk. Ann Thorac Surg (2009) 0.85
Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology. Catheter Cardiovasc Interv (2013) 0.84
Three-dimensional sensitivity assessment of thoracic aortic aneurysm wall stress: a probabilistic finite-element study. Eur J Cardiothorac Surg (2013) 0.83
Protective role of adiponectin on endothelial dysfunction induced by AGEs: a clinical and experimental approach. Microvasc Res (2011) 0.83
How should I treat a perimembranous interventricular defect following aortic valve replacement surgery? EuroIntervention (2012) 0.83
Plasma N-epsilon-(carboxymethyl)lysine levels are associated with the extent of vessel injury after coronary arterial stenting. Coron Artery Dis (2008) 0.83
Prominent role of NF-kappaB in the induction of endothelial activation by endogenous nitric oxide inhibition. Nitric Oxide (2009) 0.83
Inverse association between circulating levels of soluble receptor for advanced glycation end-products and coronary plaque burden. J Atheroscler Thromb (2012) 0.83
Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk. Curr Pharm Des (2013) 0.83
Pulmonary artery perforation by plug anchoring system after percutaneous closure of left appendage. Ann Thorac Surg (2013) 0.81
A study of the Fontan circulation and ventricular energetics based on a model. Cardiol Young (2004) 0.80
An increased platelet-leukocytes interaction at the culprit site of coronary artery occlusion in acute myocardial infarction: a pathogenic role for "no-reflow" phenomenon? Int J Cardiol (2006) 0.80
Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I. Coron Artery Dis (2011) 0.80
Quality control and the learning curve of transcatheter aortic valve implantation. JACC Cardiovasc Interv (2012) 0.80
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study. Coron Artery Dis (2011) 0.80
Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug. EuroIntervention (2016) 0.80
Cytocompatibility evaluation of gum Arabic-coated ultra-pure boron nitride nanotubes on human cells. Nanomedicine (Lond) (2014) 0.79
Transjugular tricuspid valve-in-valve implantation: a safe and effective approach. Ann Thorac Surg (2011) 0.79
Pantoprazole significantly interferes with antiplatelet effect of clopidogrel: results of a pilot randomized trial. Int J Cardiol (2012) 0.79
Impact of early abciximab administration on infarct size in patients with ST-elevation myocardial infarction. Int J Cardiol (2010) 0.78
Platelet proteome and clopidogrel response in patients with stable angina undergoing percutaneous coronary intervention. Clin Biochem (2012) 0.78
Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach. EuroIntervention (2016) 0.78
Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones. Mol Cell Biochem (2014) 0.78
Final operative and midterm results of the European experience in the RELAY Endovascular Registry for Thoracic Disease (RESTORE) study. J Vasc Surg (2010) 0.78
Transferrin-conjugated boron nitride nanotubes: protein grafting, characterization, and interaction with human endothelial cells. Int J Pharm (2012) 0.78
Sizing the annulus for transcatheter aortic valve implantation: more than a simple measure? Eur J Cardiothorac Surg (2012) 0.78
Patterns and trends of transcatheter aortic valve implantation in Italy: insights from RISPEVA. J Cardiovasc Med (Hagerstown) (2016) 0.78
Lack of effect of alpha-tocopherol on in vitro angiogenesis. Microvasc Res (2006) 0.77
[Advanced glycation endproducts: implications for accelerated atherosclerosis in diabetes]. Recenti Prog Med (2004) 0.77
Effect of the administration of n-3 polyunsaturated fatty acids on circulating levels of microparticles in patients with a previous myocardial infarction. Haematologica (2008) 0.76
Parallel decrease of tissue factor surface exposure and increase of tissue factor microparticle release by the n-3 fatty acid docosahexaenoate in endothelial cells. Thromb Haemost (2007) 0.76
Superficial coronary calcium analysis by OCT: looking forward an imaging algorithm for an automatic 3D quantification. Int J Cardiol (2013) 0.76
Reply: intracardiac echocardiographic imaging of the left atrial appendage and detection of a peridevice leak after device occlusion. JACC Cardiovasc Interv (2015) 0.75
[Author reply]. G Ital Cardiol (Rome) (2015) 0.75
Distal embolisation during carotid stenting is predicted by circulating levels of LDL cholesterol and C-reactive protein. EuroIntervention (2014) 0.75
Markers of endothelial activity are related to components of the metabolic syndrome, but not to circulating concentrations of the advanced glycation end-product N epsilon-carboxymethyl-lysine in healthy Swedish men. Atherosclerosis (2007) 0.75
Is comorbidity equivalent to symptoms in asymptomatic AS? Nat Rev Cardiol (2011) 0.75
Endovascular treatment of acute thoracic aortic syndromes with a proximal landing zone extension strategy: procedural and follow-up results. J Invasive Cardiol (2011) 0.75
Influence of involvement of anterior leaflet versus posterior leaflet on residual regurgitation as assessed by transesophageal echocardiography in patients undergoing valve repair for mitral regurgitation due to mitral valve prolapse. Cardiovasc Ultrasound (2009) 0.75
[SICI-GISE position paper on drug-coated balloon use in the coronary district]. G Ital Cardiol (Rome) (2013) 0.75
[Endothelial dysfunction. An integrated overview of the physiopatologic and diagnostic aspects]. Recenti Prog Med (2012) 0.75
[Transcatheter aortic valve implantation in patients with severe symptomatic aortic stenosis: position statement of the Italian Society of Interventional Cardiology (SICI-GISE) on minimum standards for hospitals and operators]. G Ital Cardiol (Rome) (2012) 0.75
Influence of nanoparticle-embedded polymeric surfaces on cellular adhesion, proliferation, and differentiation. J Biomed Mater Res A (2013) 0.75
Aortic arch replacement with prophylactic aortic arch debranching during type A acute aortic dissection repair: initial experience with 23 patients. Eur J Cardiothorac Surg (2011) 0.75
Balloon valuloplasty prior to transcatheter valve-in-valve implantation in a degenerated Mitroflow aortic bioprosthesis. Catheter Cardiovasc Interv (2012) 0.75
Simultaneous transapical paraprosthetic leak occlusion and valve-in-valve implantation into a degenerated mitral bioprosthesis. J Heart Valve Dis (2014) 0.75
[Door-to-balloon time and in-hospital mortality in patients with ST-evaluation myocardial infarction: a network experience in a province in northwest Tuscany, Italy]. G Ital Cardiol (Rome) (2010) 0.75
A multimarker study of degenerative aortic valve disease: stenoinsufficiency shows more indices of bad prognosis. Cardiology (2013) 0.75
[Transcatheter treatment of aortic stenosis in Italy]. G Ital Cardiol (Rome) (2014) 0.75
Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol (2002) 0.75
[SICI-GISE position paper on the requirements for diagnostic and interventional procedures in patients with peripheral arterial disease]. G Ital Cardiol (Rome) (2013) 0.75
[Common pathogenetic features between calcific aortic stenosis and atherosclerosis: role of receptor for advanced glycation end-products]. Recenti Prog Med (2010) 0.75
[Thrombolysis accelerated by ultrasound and microbubbles]. Ital Heart J Suppl (2003) 0.75
Can Dietary Polyphenols Prevent the Formation of Toxic Compounds from Maillard Reaction? Curr Drug Metab (2016) 0.75
Mathematical modelling of the impact of preoperative hypertrophy on the outcomes of completion of the Fontan circuit. Cardiol Young (2005) 0.75
[Venous graft in-stent restanosis: diagnostic and treatment evolution]. Recenti Prog Med (2011) 0.75